1. What's the timeline for a coronavirus vaccine? p3  NewsChannel 5
  2. Exclusive: U.S. plans massive coronavirus vaccine testing effort to meet year-end deadline  The Star Online
  3. Mobius Says Covid-19 Vaccine Isn't the Answer to Recovery  Bloomberg Markets and Finance
  4. Race to Successful COVID Vaccine May Shape India’s Global Position  The Quint
  5. Op-Ed: Fast coronavirus vaccine could bring problems  Los Angeles Times
  6. View Full coverage on Google News
ONDON, May 22 — Oxford University said today it is recruiting thousands of volunteers for the next phase in human trials of a coronavirus vaccine that it says are “progressing very well”. Up to 10,260 adults and children will be enrolled as it expands the age range of people given the...ONDON, May 22 — Oxford University said today it is recruiting thousands of volunteers for the next phase in human trials of a coronavirus vaccine that it says are “progressing very well”. Up to 10,260 adults and children will be enrolled as it expands the age range of people given the...

Oxford expands Covid-19 vaccine trial to older adults and children | Life | Malay Mail

Bloomberg - Are you a robot?

Poor communication from Jonas Salk and lax regulation led to unecessary suffering in the polio vaccine rush. Trump may be repeating the same mistakes.Poor communication from Jonas Salk and lax regulation led to unecessary suffering in the polio vaccine rush. Trump may be repeating the same mistakes.

Epidemiologist warns: Trump's vaccine push may be dangerous - Los Angeles Times

“This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering.”

Bernie Sanders on Twitter: "This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering."

“Oxford, AstraZeneca begin advanced trials of Covid vaccine @LauermanJohn reports https://t.co/baA6VZECin”

Shekhar Gupta on Twitter: "Oxford, AstraZeneca begin advanced trials of Covid vaccine @LauermanJohn reports https://t.co/baA6VZECin"

“$JNJ Chinese Covid-19 Vaccine Trial Results Are a Good Sign for J&J and AstraZeneca’s Efforts https://t.co/u2qIOVySFY”

Ophir Gottlieb on Twitter: "$JNJ Chinese Covid-19 Vaccine Trial Results Are a Good Sign for J&J and AstraZeneca’s Efforts https://t.co/u2qIOVySFY"

“US provides AstraZeneca with $1 billion for COVID-19 vaccine #GeoNews”

Geo English on Twitter: "US provides AstraZeneca with $1 billion for COVID-19 vaccine #GeoNews"

THE US has purchased around 300 million COVID-19 vaccines from AsteaZeneca.THE US has purchased around 300 million COVID-19 vaccines from AsteaZeneca.

Coronavirus US: 300 million AstraZeneca vaccines bought | World | News | Express.co.uk

Anthony Fauci cautioned Wednesday that using the name 'Operation Warp Speed' to prioritize the initiative to get a vaccine approved for coronavirus could embolden the anti-vaccine movement.Anthony Fauci cautioned Wednesday that using the name 'Operation Warp Speed' to prioritize the initiative to get a vaccine approved for coronavirus could embolden the anti-vaccine movement.

Fauci fears anti-vaxxers will exploit 'Operation Warp Speed' | Daily Mail Online

An Oxford University team are already mass producing a possible vaccine on an industrial scale before animal and human trials indicate whether it can lead to serious immune systems complications An Oxford University team are already mass producing a possible vaccine on an industrial scale before animal and human trials indicate whether it can lead to serious immune systems complications

Coronavirus vaccine set for early autumn - but scientist warns of deadly risk - Mirror Online

403 Missing Auth Token

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Subscribe to read | Financial Times

Slaoui, an immunologist has already developed 24 vaccines to combat Ebola, malaria and abdominal infections - Anadolu AgencySlaoui, an immunologist has already developed 24 vaccines to combat Ebola, malaria and abdominal infections - Anadolu Agency

Trump’s vaccine chief has a Moroccan background

UK News: LONDON: Clinical trials to test Oxford University’s new vaccine for Covid-19 are “progressing very well”, the head of the Oxford Vaccine Group (OVG) s.UK News: LONDON: Clinical trials to test Oxford University’s new vaccine for Covid-19 are “progressing very well”, the head of the Oxford Vaccine Group (OVG) s.

Oxford vaccine clinical trials are 'going well' - Times of India

Only days after Moderna reported positive early results for its potential COVID-19 vaccine, AstraZeneca has stolen the spotlight back. On Thursday, the U.K. drug giant scored a $1 billion contribution from the United States for development, production and delivery of its potential shot starting this fall. Only days after Moderna reported positive early results for its potential COVID-19 vaccine, AstraZeneca has stolen the spotlight back. On Thursday, the U.K. drug giant scored a $1 billion contribution from the United States for development, production and delivery of its potential shot starting this fall. 

AstraZeneca scores $1.2B from U.S., signs up to deliver hundreds of millions of COVID-19 vaccines | FiercePharma

The London Economic |"That is going to mean a lot of elderly are going to die and those with heart conditions and diabetes and other risk factors.' | NewsThe London Economic |"That is going to mean a lot of elderly are going to die and those with heart conditions and diabetes and other risk factors.' | News

Herd immunity without vaccine or treatment is a 'Darwinian policy'

Operation Warp Speed's funding of AstraZeneca is intended to deliver a COVID-19 vaccine by October, although some call that timeline unrealistic.Operation Warp Speed's funding of AstraZeneca is intended to deliver a COVID-19 vaccine by October, although some call that timeline unrealistic.

Doubts greet $1.2 billion bet by United States on a coronavirus vaccine by October | Science | AAAS

US secures 300 million. Read more at straitstimes.com.World News -US secures 300 million. Read more at straitstimes.com.

In Brief: US secures 300 million possible vaccine doses, World News & Top Stories - The Straits Times

Early progress has been reported on several vaccine efforts, as scientists around the world scramble to test ways to protect people from the coronavirus.Early progress has been reported on several vaccine efforts, as scientists around the world scramble to test ways to protect people from the coronavirus.

For all The Spinoff’s latest coverage of Covid-19 see here. Read Siouxsie Wiles’s work here. New Zealand is currently in alert level two – read The Spinoff’s giant explainer about what that means here. For official government advice, see here. The Spinoff’s coverage of the Covid-19 outbreak is fuFor all The Spinoff’s latest coverage of Covid-19 see here. Read Siouxsie Wiles’s work here. New Zealand is currently in alert level two – read The Spinoff’s giant explainer about what that means here. For official government advice, see here. The Spinoff’s coverage of the Covid-19 outbreak is fu

Covid-19 live updates, May 23: No new cases; NZ company joins vaccine race | The Spinoff

The Oxford trial will monitor the effects on thousands of people's immune systems.The Oxford trial will monitor the effects on thousands of people's immune systems.

Coronavirus: Children and older adults to take part in vaccine trial - BBC News

British pharmaceutical company AstraZeneca says it is ready to provide a potential vaccine against the new coronavirus from September.British pharmaceutical company AstraZeneca says it is ready to provide a potential vaccine against the new coronavirus from September.

British firm ready to supply vaccine in September | NHK WORLD-JAPAN News

By pledging up to $1.2 billion in assistance, the Department of Health and Human Services has ensured its access to a large supply of the ChAdOx1 nCoV-19 vaccine -- assuming it works.By pledging up to $1.2 billion in assistance, the Department of Health and Human Services has ensured its access to a large supply of the ChAdOx1 nCoV-19 vaccine -- assuming it works.

U.S. Seals Deal with AstraZeneca for 300 Million Doses of Potential Coronavirus Vaccine | The Motley Fool

An update on AstraZeneca’s COVID-19 vaccine candidate, AZD1222, reveals the firm has secured capacity to make one billion doses, with the first deliveries plann

First 400 million COVID-19 vaccine doses earmarked for UK and USA

British researchers testing an experimental vaccine against the new coronavirus are moving into advanced studies and aim to immunize more than 10,000 people to determine if the shot works.

UK to start huge vaccine test; China reports promising hints (Update)

Researchers at Oxford University said on Friday that they would move to the next phase of testing, expanding from 1,000 people to some 10,000 more.Researchers at Oxford University said on Friday that they would move to the next phase of testing, expanding from 1,000 people to some 10,000 more.

Oxford vaccine 'progressing very well,' 10,000 more to be inoculated - Business Insider

“The clinical studies are progressing very well and we are now initiating studies to evaluate how well the vaccine induces immune responses in older adults,” Andrew Pollard, head of the Oxford Vaccine Group, said.“The clinical studies are progressing very well and we are now initiating studies to evaluate how well the vaccine induces immune responses in older adults,” Andrew Pollard, head of the Oxford Vaccine Group, said.

Oxford’s coronavirus vaccine trial progressing ‘very well’, on to second phase now - world news - Hindustan Times

Pending the results of a Phase III efficacy trial this summer, a vaccine produced by the biotech company Moderna could be ready for approval as soon as the fall.Pending the results of a Phase III efficacy trial this summer, a vaccine produced by the biotech company Moderna could be ready for approval as soon as the fall.

The Coronavirus Vaccine Is on Track to Be the Fastest Ever Developed | The New Yorker

If and when the vaccine becomes available, the first 400 million doses go to AmericaIf and when the vaccine becomes available, the first 400 million doses go to America

British researchers testing an experimental vaccine against the new coronavirus are moving into advanced studies and aim to immunize more than 10,000 peoplBritish researchers testing an experimental vaccine against the new coronavirus are moving into advanced studies and aim to immunize more than 10,000 peopl

U.K.'s COVID-19 Study Aims to Vaccinate More Than 10,000 | Hamodia.com

AstraZeneca is also in discussions with the Serum Institute of India and other potential partners to increase production and distribution.AstraZeneca is also in discussions with the Serum Institute of India and other potential partners to increase production and distribution.

AstraZeneca receives $1bn US investment for Oxford vaccine, Health News, ET HealthWorld

AstraZeneca is partnering with University of Oxford to develop and distribute a vaccine being trialled in the UKAstraZeneca is partnering with University of Oxford to develop and distribute a vaccine being trialled in the UK

US provides AstraZeneca with $1 billion for COVID-19 vaccine

As states continue to reopen after weeks-long shutdowns shuttered businesses, the number of unemployed Americans continues to rise. On Thursday, the Labor...As states continue to reopen after weeks-long shutdowns shuttered businesses, the number of unemployed Americans continues to rise. On Thursday, the Labor Department announced 2.4 million people sought jobless benefits last week, bringing the total to nearly 39 million in the past two months.

US Virus Updates: Remdesivir Clinical Trial Results; CDC’s Guidelines for ‘Communities of Faith’ – NBC 6 South Florida

KIDS and over 70s are to trial the Oxford University coronavirus jab. More than 10,200 people – including older adults and five to 12-year-olds – will be included in the second phase of…

Kids and over 70s to trial Oxford Uni coronavirus jab – as scientists aim for first doses this year – The Sun

Biotech companies and drugmakers are speeding up development of a vaccine for COVID-19. This has seen many big players joining forces to come up with a treatment.Biotech companies and drugmakers are speeding up development of a vaccine for COVID-19. This has seen many big players joining forces to come up with a treatment.

Coronavirus Vaccine Race Pushes Up Pharma Giants' Production

AstraZeneca has announced a deal to distribute 400 million doses of Oxford Uni's coronavirus vaccine, but the vaccine may not work.AstraZeneca has announced a deal to distribute 400 million doses of Oxford Uni's coronavirus vaccine, but the vaccine may not work.

3 Reasons Why Oxford’s Record-Breaking COVID-19 Vaccine is a Risky Bet

Britain has the world's second-highest death toll in the coronavirus pandemic, and has faced sustained criticism for its response to the outbreak.Britain has the world's second-highest death toll in the coronavirus pandemic, and has faced sustained criticism for its response to the outbreak.

Virus-stung UK banks on vaccine drive [ARTICLE] - Pulse Nigeria

AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on ...AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on ...

Drugmaker AstraZeneca to make a billion COVID-19 vaccine doses if tests succeed - CNA

THE United States has secured almost a third of AstraZeneca's one billion possible Covid-19 vaccine doses by pledging up to US$1.2 billion, as the world's biggest powers scramble for medicinal supplies to get their economies back to work. Read more at The Business Times.THE United States has secured almost a third of AstraZeneca's one billion possible Covid-19 vaccine doses by pledging up to US$1.2 billion, as the world's biggest powers scramble for medicinal

US secures 300 million doses of potential Covid-19 vaccine, Government & Economy - THE BUSINESS TIMES

Oxford University and AstraZeneca are recruiting around 10,000 adults and children in Britain for trials of an experimental coronavirus vaccine, a day after receiving U.S. backing worth up to $1.2 billion.Oxford University and AstraZeneca are recruiting around 10,000 adults and children in Britain for trials of an experimental coronavirus vaccine, a day after receiving U.S. backing worth up to $1.2 billion.

Human trials of British coronavirus vaccine to reach 10,000 - Reuters

The United States has secured almost a third of the first one billion doses planned for AstraZeneca's experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work.The United States has secured almost a third of the first one billion doses planned for AstraZeneca's experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work.

‘America first’: US secures 300 million doses of potential UK COVID-19 vaccine – EURACTIV.com

404 Not Found

Waterford's Jared Burrows, the winning pitcher in the 2019 Class L state championship game, was named the 2020 Gatorade Connecticut Baseball Player of theThe crowded walls of the place affectionately known as "The X" got more cramped Thursday, a new banner forthcoming even without a spring of high

The Day - Waterford's Burrows named Gatorade Connecticut Baseball Player of the Year - News from southeastern Connecticut

Drugmaker says it is capable of producing 1 billion doses of the AZD1222 vaccineDrugmaker says it is capable of producing 1 billion doses of the AZD1222 vaccine

Coronavirus: AstraZeneca ready to supply potential vaccine in September | World – Gulf News

The coronavirus vaccine race delivers more promising news, as the US invested $1.2 billion to speed up development and secure 300 million doses for the breakthrough Oxford candidate.The coronavirus vaccine race delivers more promising news, as the US invested $1.2 billion to speed up development and secure 300 million doses for the breakthrough Oxford candidate. The novel coro…

US secures 300M doses of coronavirus vaccine candidate from Oxford – BGR

About 10,000 people are due to receive the Oxford vaccine at sites around the country as trials move into their final phases.The announcement that scientists are recruiting volunteers en masseAbout 10,000 people are due to receive the Oxford vaccine at sites around the country as trials move into their final phases.The announcement that scientists are recruiting volunteers en masse